Molecular Templates Valuation
| MTEM Stock | USD 0.38 0.01 2.56% |
Molecular Templates seems to be undervalued based on Macroaxis valuation methodology. Our model forecasts the value of Molecular Templates from analyzing the firm fundamentals such as Current Valuation of 1.29 M, return on equity of -9.29, and Profit Margin of (0.61) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Molecular Templates' valuation include:
Price Book 0.3592 | Enterprise Value 1.3 M | Enterprise Value Ebitda 0.1468 | Price Sales 0.1003 | Enterprise Value Revenue 0.0548 |
Undervalued
Today
Please note that Molecular Templates' price fluctuation is dangerous at this time. Calculation of the real value of Molecular Templates is based on 3 months time horizon. Increasing Molecular Templates' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Molecular stock is determined by what a typical buyer is willing to pay for full or partial control of Molecular Templates. Since Molecular Templates is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Molecular Stock. However, Molecular Templates' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.38 | Real 9.66 | Target 37.5 | Hype 0.37 | Naive 0.31 |
The intrinsic value of Molecular Templates' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Molecular Templates' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Molecular Templates helps investors to forecast how Molecular stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molecular Templates more accurately as focusing exclusively on Molecular Templates' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Molecular Templates' intrinsic value based on its ongoing forecasts of Molecular Templates' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Molecular Templates' closest peers.
Molecular Templates Cash |
|
Molecular Valuation Trend
Knowing Molecular Templates' actual value is paramount for traders when making sound investment determinations. Using both Molecular Templates' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Molecular Templates Total Value Analysis
Molecular Templates is now forecasted to have valuation of 1.29 M with market capitalization of 2.55 M, debt of 12.23 M, and cash on hands of 104.42 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Molecular Templates fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.29 M | 2.55 M | 12.23 M | 104.42 M |
Molecular Templates Investor Information
About 35.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Molecular Templates recorded a loss per share of 3.05. The entity last dividend was issued on the 2nd of August 2017. The firm had 1:15 split on the 14th of August 2023. Based on the key indicators related to Molecular Templates' liquidity, profitability, solvency, and operating efficiency, Molecular Templates is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Molecular Templates Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Molecular Templates has an asset utilization ratio of 161.96 percent. This suggests that the Company is making $1.62 for each dollar of assets. An increasing asset utilization means that Molecular Templates is more efficient with each dollar of assets it utilizes for everyday operations.Molecular Templates Ownership Allocation
30% of Molecular Templates outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.Molecular Templates Profitability Analysis
The company reported the previous year's revenue of 57.31 M. Net Loss for the year was (8.12 M) with loss before overhead, payroll, taxes, and interest of (45.97 M).About Molecular Templates Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Molecular Templates. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Molecular Templates based exclusively on its fundamental and basic technical indicators. By analyzing Molecular Templates's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Molecular Templates's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Molecular Templates. We calculate exposure to Molecular Templates's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Molecular Templates's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 50.4 M | 52.9 M | |
| Pretax Profit Margin | (0.14) | (0.15) | |
| Operating Profit Margin | (0.18) | (0.19) | |
| Net Loss | (0.14) | (0.15) | |
| Gross Profit Margin | 0.88 | 0.92 |
Molecular Templates Growth Indicators
Investing in growth stocks can be very risky. If the company such as Molecular Templates does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.5 M | |
| Quarterly Earnings Growth Y O Y | -0.972 |
Molecular Templates Current Valuation Indicators
Molecular Templates' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Molecular Templates' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Molecular Templates, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Molecular Templates' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Molecular Templates' worth.When determining whether Molecular Templates is a strong investment it is important to analyze Molecular Templates' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Molecular Templates' future performance. For an informed investment choice regarding Molecular Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Templates. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.